BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 19301021)

  • 1. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
    Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
    Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
    Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
    J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hair growth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe.
    Ali A; Martin JM
    J Drugs Dermatol; 2010 Jan; 9(1):62-4. PubMed ID: 20120427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PUVA treatment of alopecia areata.
    Claudy AL; Gagnaire D
    Arch Dermatol; 1983 Dec; 119(12):975-8. PubMed ID: 6651314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata treated with topical minoxidil.
    Weiss VC; West DP; Fu TS; Robinson LA; Cook B; Cohen RL; Chambers DA
    Arch Dermatol; 1984 Apr; 120(4):457-63. PubMed ID: 6703751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata: evidence-based treatments.
    Garg S; Messenger AG
    Semin Cutan Med Surg; 2009 Mar; 28(1):15-8. PubMed ID: 19341938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
    Nakajima T; Inui S; Itami S
    Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
    Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
    Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year experience in the treatment of alopecia areata with DPC.
    El-Zawahry BM; Bassiouny DA; Khella A; Zaki NS
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):264-9. PubMed ID: 19744175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of persistent alopecia areata with sulfasalazine.
    Rashidi T; Mahd AA
    Int J Dermatol; 2008 Aug; 47(8):850-2. PubMed ID: 18717871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata.
    Kurosawa M; Nakagawa S; Mizuashi M; Sasaki Y; Kawamura M; Saito M; Aiba S
    Dermatology; 2006; 212(4):361-5. PubMed ID: 16707886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alopecia areata: update on therapy].
    Assouly P
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):831-6. PubMed ID: 12223967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen.
    Mohamed Z; Bhouri A; Jallouli A; Fazaa B; Kamoun MR; Mokhtar I
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):552-5. PubMed ID: 16164707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
    Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
    Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.